BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9291126)

  • 1. Scavenger receptor B1 (SR-B1) substrates inhibit the selective uptake of high-density-lipoprotein cholesteryl esters by rat parenchymal liver cells.
    Fluiter K; van Berkel TJ
    Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):515-9. PubMed ID: 9291126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scavenger receptor class B, type I (SR-BI) is the major route for the delivery of high density lipoprotein cholesterol to the steroidogenic pathway in cultured mouse adrenocortical cells.
    Temel RE; Trigatti B; DeMattos RB; Azhar S; Krieger M; Williams DL
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13600-5. PubMed ID: 9391072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New scavenger receptor-like receptors for the binding of lipopolysaccharide to liver endothelial and Kupffer cells.
    van Oosten M; van de Bilt E; van Berkel TJ; Kuiper J
    Infect Immun; 1998 Nov; 66(11):5107-12. PubMed ID: 9784510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcal serum opacity factor increases the rate of hepatocyte uptake of human plasma high-density lipoprotein cholesterol.
    Gillard BK; Rosales C; Pillai BK; Lin HY; Courtney HS; Pownall HJ
    Biochemistry; 2010 Nov; 49(45):9866-73. PubMed ID: 20879789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary roles for scavenger receptor A and CD36 of human monocyte-derived macrophages in adhesion to surfaces coated with oxidized low-density lipoproteins and in secretion of H2O2.
    Maxeiner H; Husemann J; Thomas CA; Loike JD; El Khoury J; Silverstein SC
    J Exp Med; 1998 Dec; 188(12):2257-65. PubMed ID: 9858512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells.
    Hu Z; Shen WJ; Kraemer FB; Azhar S
    Mol Cell Biol; 2012 Dec; 32(24):5035-45. PubMed ID: 23045399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux.
    Shen WJ; Azhar S; Kraemer FB
    Annu Rev Physiol; 2018 Feb; 80():95-116. PubMed ID: 29125794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental glomerulopathy alters renal cortical cholesterol, SR-B1, ABCA1, and HMG CoA reductase expression.
    Johnson AC; Yabu JM; Hanson S; Shah VO; Zager RA
    Am J Pathol; 2003 Jan; 162(1):283-91. PubMed ID: 12507911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adaptor protein GIPC1 stabilizes the scavenger receptor SR-B1 and increases its cholesterol uptake.
    Zhang Z; Zhou Q; Liu R; Liu L; Shen WJ; Azhar S; Qu YF; Guo Z; Hu Z
    J Biol Chem; 2021; 296():100616. PubMed ID: 33811857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute tubular injury causes dysregulation of cellular cholesterol transport proteins.
    Zager RA; Johnson AC; Hanson SY; Shah VO
    Am J Pathol; 2003 Jul; 163(1):313-20. PubMed ID: 12819036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of high-density lipoprotein by scavenger receptor class B type 1 is associated with prostate cancer proliferation and tumor progression in mice.
    Traughber CA; Opoku E; Brubaker G; Major J; Lu H; Lorkowski SW; Neumann C; Hardaway A; Chung YM; Gulshan K; Sharifi N; Brown JM; Smith JD
    J Biol Chem; 2020 Jun; 295(24):8252-8261. PubMed ID: 32358065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein A1 and high-density lipoprotein limit low-density lipoprotein transcytosis by binding SR-B1.
    Fung KYY; Ho TWW; Xu Z; Neculai D; Beauchemin CAA; Lee WL; Fairn GD
    J Lipid Res; 2024 Apr; 65(4):100530. PubMed ID: 38479648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of plasma protein binding and in vivo liver cell uptake of phosphorothioate oligodeoxynucleotides by cholesterol conjugation.
    Bijsterbosch MK; Rump ET; De Vrueh RL; Dorland R; van Veghel R; Tivel KL; Biessen EA; van Berkel TJ; Manoharan M
    Nucleic Acids Res; 2000 Jul; 28(14):2717-25. PubMed ID: 10908328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 17β-estradiol on cholesterol content in human macrophages is influenced by the lipoprotein milieu.
    Corcoran MP; Lichtenstein AH; Meydani M; Dillard A; Schaefer EJ; Lamon-Fava S
    J Mol Endocrinol; 2011 Aug; 47(1):109-117. PubMed ID: 21830321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis.
    Rink JS; Lin AY; McMahon KM; Calvert AE; Yang S; Taxter T; Moreira J; Chadburn A; Behdad A; Karmali R; Thaxton CS; Gordon LI
    J Biol Chem; 2021; 296():100100. PubMed ID: 33208460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PON1 has palmitoyl-protein thioesterase (PPT) activity, and can affect the presence of SR-B1 on the endothelial cell membrane.
    Ashkar R; Khattib A; Musa S; Goldberg D; Khatib S
    Biofactors; 2024; 50(3):608-618. PubMed ID: 38135490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a purification system for functional full-length human SR-B1 and CD36.
    Powers HR; Jenjak SE; Volkman BF; Sahoo D
    J Biol Chem; 2023 Oct; 299(10):105187. PubMed ID: 37625590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathways for Modulating Exosome Lipids Identified By High-Density Lipoprotein-Like Nanoparticle Binding to Scavenger Receptor Type B-1.
    Angeloni NL; McMahon KM; Swaminathan S; Plebanek MP; Osman I; Volpert OV; Thaxton CS
    Sci Rep; 2016 Mar; 6():22915. PubMed ID: 26964503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle Targeting in Chemo-Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance.
    Wang Y; Calvert AE; Cardenas H; Rink JS; Nahotko D; Qiang W; Ndukwe CE; Chen F; Keathley R; Zhang Y; Cheng JX; Thaxton CS; Matei D
    Adv Sci (Weinh); 2024 Apr; 11(13):e2305212. PubMed ID: 38263873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging.
    Mooberry LK; Sabnis NA; Panchoo M; Nagarajan B; Lacko AG
    Front Pharmacol; 2016; 7():466. PubMed ID: 28018216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.